Tags:BioTechEnterpriseFinTechHealthInvestmentLifeLocalOrganicPlatformResearchScienceServiceSocialSocietySoftwareSpaceTechnology
o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life. o2h is organised into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h therapeutics, o2h technology, o2h co-work, and o2h community. o2h ventures is an engine for nurturing early stage life science and technology assets through seed investment. o2h Discovery is an integrated chemistry and biology services platform for executing collaborative research. o2h technology works on proprietary software projects for in-house portfolio companies. o2h Therapeutics is a seeding a novel pipeline of proprietary pre-clinical IP in Immunoncology (glioblastoma, breast cancer), anti-ageing and diabetes. o2h co-working space located in Hauxton, Cambridge, UK and o2h community covers our work with local non-profits organisations, our interests in working with social enterprise and our work in creating a community of innovators that can impact society. o2h group is co-located in Ahmedabad, India and in Cambridge UK. Please see www.o2h.com for more details.
Likes
1702
Location: India, Gujarat, Ahmedabad
Phone: +91 2717 656 408
Founded date: 2005

Investors 1

Mentions in press and media 17

DateTitleDescriptionCategoryAuthorSource
24.09.2021o2h co-wor...o2h co-work labs, a business u...--cambridgen...
24.09.2021o2h co-wor...o2h co-work labs launches the ...--cambridgen...
13.11.2020o2h ventur...o2h ventures has announced the...--cambridgen...
13.11.2020o2h ventur...o2h ventures launches the firs...--cambridgen...
30.06.2020Cambridge ...PharmEnable, a Cambridge-based...--cambridgen...
30.06.2020Cambridge ...Cambridge spin-out PharmEnable...--cambridgen...
12.03.2020Cofinitive...Cofinitive shortlisted in 30th...--cambridgen...
08.11.2019Cambridge ...Cambridge companies recognised...--cambridgen...
13.09.2019Wood­ford ...→ Neil Wood­ford‘s in­vest­men...-Endpoints ...endpts.com...
19.06.2019Oxford Dru...Oxford Drug Design receives ov...--cambridgen...
Show more